JATT II Acquisition Corp. (JATT) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $79.8M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerJATT II Acquisition Corp. (JATT) trades at $10.23. JATT Acquisition Corp is a shell company focused on merging with or acquiring a business in the life sciences sector. Market cap: $79.8M, Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for JATT: JATT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
JATT II Acquisition Corp. (JATT) Financial Services Profile
JATT Acquisition Corp, a special purpose acquisition company (SPAC), targets a business combination within the life sciences sector. Incorporated in 2021 and based in the Cayman Islands, JATT seeks to identify and merge with a promising entity, offering investors exposure to a potentially high-growth opportunity.
What Is the Investment Thesis for JATT?
JATT Acquisition Corp presents a speculative investment opportunity, contingent on its ability to identify and complete a successful merger within the life sciences sector. With a market capitalization of $79.8M and a negative P/E ratio of -22.82, the company's valuation is largely based on its potential future acquisition target. The absence of a dividend reflects its current operational status as a shell company. Key value drivers include the management team's expertise in identifying and executing acquisitions, the attractiveness of the life sciences sector, and the potential for significant value creation through a successful merger. The timeline for realizing this value is uncertain, as it depends on the company's ability to find a suitable target and complete the transaction. Potential risks include the failure to identify a target, unfavorable market conditions, and regulatory hurdles.
Based on FMP financials and quantitative analysis
JATT Key Highlights
Market capitalization of $79.8M reflects the company's status as a special purpose acquisition company (SPAC).
- Negative P/E ratio of -22.82 indicates the company's current lack of profitability due to its operational status.
- Focus on the life sciences sector provides exposure to a high-growth industry with significant innovation potential.
- Absence of a dividend reflects the company's reinvestment of capital towards identifying and completing a business combination.
- Incorporated in 2021, JATT is actively pursuing a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination.
Who Are JATT's Competitors?
JATT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AIB AIB Acquisition Corporation | $0.63 | -3.82% | $48.5M | 30 5-pillar |
| ACBA Ace Global Business Acquisition Limited | $12.03 | -0.58% | $41.3M | — |
| EUCR Eucrates Biomedical Acquisition Corp. | $10.04 | 0.00% | $42.2M | — |
| CPBI Central Plains Bancshares, Inc. | $20.51 | -0.34% | $79.4M | 73 5-pillar |
| WSTN Westin Acquisition Corp | $10.25 | +0.20% | $81.1M | 52 5-pillar |
| MACI Melar Acquisition Corp. I | $8.20 | -1.80% | $78.3M | 43 5-pillar |
| APAC StoneBridge Acquisition Corporation | $10.32 | 0.00% | $83.1M | 53 5-pillar |
| BPAC Bullpen Parlay Acquisition Company | $10.31 | +0.19% | $76.1M | 51 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JATT's Key Strengths?
Experienced management team with expertise in acquisitions.
- Focus on the high-growth life sciences sector.
- Access to capital through its IPO.
- Flexibility to pursue various types of business combinations.
What Are JATT's Weaknesses?
Lack of operating history and revenue.
- Dependence on identifying and completing a successful acquisition.
- Intense competition from other SPACs.
- Uncertainty regarding the timing and terms of a potential acquisition.
What Are the Key Risks for JATT?
Negative return on equity (-76.8%) — the business is not currently generating profit on shareholder capital.
- Failure to identify a suitable target company within the specified timeframe.
- Inability to complete a transaction on favorable terms.
- Regulatory hurdles and delays in obtaining necessary approvals.
- Intense competition from other SPACs seeking acquisitions in the life sciences sector.
- Market volatility and economic downturns that could negatively impact investor sentiment.
What Are JATT's Competitive Advantages?
- Management Team Expertise: JATT's management team's expertise in identifying and executing acquisitions in the life sciences sector provides a competitive advantage.
- Access to Capital: JATT's access to capital through its IPO provides a financial advantage in pursuing potential acquisitions.
- Industry Network: JATT's network of relationships within the life sciences industry can facilitate access to potential target companies.
What Does JATT Do?
JATT Acquisition Corp, incorporated in 2021, operates as a blank check company, also known as a special purpose acquisition company (SPAC). Headquartered in Grand Cayman, Cayman Islands, JATT was formed with the primary objective of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Unlike traditional operating companies, JATT currently has no significant operations of its own. The company's strategy is centered on identifying and partnering with a private company, primarily within the life sciences sector, to bring it to the public market. This process involves thorough due diligence and negotiation to ensure a mutually beneficial agreement. Upon successful completion of a business combination, the private company effectively becomes a publicly traded entity through its merger with JATT. JATT's focus on the life sciences sector reflects the potential for innovation and growth within this industry, driven by advancements in biotechnology, pharmaceuticals, and healthcare technologies. The company's success hinges on its ability to identify and secure a compelling target with strong growth prospects and a capable management team. The ultimate goal is to create value for shareholders by facilitating the public listing of a promising life sciences company.
What Products and Services Does JATT Offer?
- JATT Acquisition Corp is a special purpose acquisition company (SPAC).
- It is designed to identify and merge with a private company.
- JATT focuses primarily on businesses operating in the life sciences sector.
- The company aims to bring a private life sciences company to the public market.
- JATT facilitates a business combination through a merger, capital share exchange, or asset acquisition.
- It provides an alternative route for private companies to go public, bypassing the traditional IPO process.
How Does JATT Make Money?
- JATT raises capital through an initial public offering (IPO).
- The raised capital is held in a trust account and used to fund the acquisition of a target company.
- JATT generates returns for its shareholders through the appreciation of the acquired company's stock price after the merger.
What Industry Does JATT Operate In?
JATT Acquisition Corp operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). SPACs have become increasingly popular as an alternative route for private companies to go public, bypassing the traditional IPO process. The market for SPACs is influenced by overall market sentiment, regulatory changes, and investor appetite for risk. The life sciences sector, which JATT targets, is characterized by high growth potential, driven by innovation in biotechnology, pharmaceuticals, and healthcare technologies. Competition among SPACs for attractive targets in the life sciences sector is intense, requiring JATT to differentiate itself through its expertise and network.
Who Are JATT's Key Customers?
- JATT's primary customers are its shareholders, who invest in the company with the expectation of generating returns through a successful acquisition.
- Potential target companies in the life sciences sector seeking to go public.
- Institutional investors who participate in the IPO and subsequent offerings.
Research confidence
Thin evidence — scored on only 24% of our measures. Treat this as a starting point, not a conclusion.
- ● Scored on only 24% of our measures
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a spac, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 75 snapshots
| 2026-08-23 | 69 |
| 2026-09-07 | 69 |
| 2026-09-22 | 69 |
| 2026-10-12 | 69 |
| 2026-11-01 | 69 |
| 2026-11-19 | 69 |
What changed?
The score has stayed at 69.
Over the same 30 days the stock moved -0.8%.
Key Financial Metrics
Return on equity for JATT II Acquisition Corp. stands at -76.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -46.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -88.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 19.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -9.2%, the inverse of the P/E and a quick read on earnings relative to price.
JATT II Acquisition Corp. (JATT) Valuation Context
Valued at $79.8M, JATT is classified as a micro-cap stock.
Company Profile
JATT II Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Westfield, US. The company is led by CEO Someit Sidhu. JATT has traded publicly since 2026.
JATT Financials
Bull Case vs Bear Case
Bull Case
- Experienced management team with expertise in acquisitions.
- Focus on the high-growth life sciences sector.
- Access to capital through its IPO.
- Flexibility to pursue various types of business combinations.
Bear Case
- Lack of operating history and revenue.
- Dependence on identifying and completing a successful acquisition.
- Intense competition from other SPACs.
- Uncertainty regarding the timing and terms of a potential acquisition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
JATT Latest News
No recent news available for JATT.
JATT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for JATT.
Price Targets
Wall Street price target analysis for JATT.
JATT MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for JATT; grades run from A+ (80-100) to F (below 30).
Leadership: Someit Sidhu
CEO
Someit Sidhu serves as the CEO of JATT Acquisition Corp. His background includes extensive experience in the financial services sector, with a focus on investment banking and mergers and acquisitions. Prior to joining JATT, Mr. Sidhu held various leadership positions at leading financial institutions, where he advised companies on strategic transactions and capital raising initiatives. He holds an MBA from a top-tier business school and a bachelor's degree in finance.
Track Record: Under Mr. Sidhu's leadership, JATT Acquisition Corp has been actively pursuing potential acquisition targets in the life sciences sector. While the company has not yet completed a merger, Mr. Sidhu has overseen the evaluation of numerous opportunities and has been instrumental in developing the company's acquisition strategy. His experience and network within the financial services industry are expected to be valuable in identifying and executing a successful transaction.
What Investors Ask About JATT II Acquisition Corp. (JATT) — Financials
What do analysts say about JATT stock?
As of March 18, 2026, there is limited analyst coverage on JATT Acquisition Corp due to its nature as a SPAC.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.